MGO One Seven’s Cocrystal Pharma COCP Stock Holding History

MGO One Seven’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1K	Buy	+17	New	+$1.06K	﹤0.01%	1636

Other funds holding COCP

Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Centerpoint Advisors Needham, Massachusetts $307M AUM 19.69% 1-Year Est. Return

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

MGO One Seven's COCP Position: Q1 2018 in Review

MGO One Seven opened a new position in Cocrystal Pharma (COCP) in Q1 2018: 17 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1636 among its holdings.

13 funds tracked by Wall St. Rank hold COCP as of Q1 2018.

MGO One Seven held 17 shares of Cocrystal Pharma worth $1K as of Q1 2018.
Cocrystal Pharma was a new MGO One Seven position in Q1 2018.
Cocrystal Pharma made up ﹤0.01% of MGO One Seven's portfolio in Q1 2018, its #1636 holding.
13 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.